Lamas José Luis, Ocampo Antonio, Martínez-Vázquez César, Miralles Celia, Longueira Rebeca, Arias Mercedes, Sopeña Bernardo, Rivera Alberto, Portela Daniel
Unidad de Enfermedades Infecciosas, Servicio de Medicina Interna, Complejo Hospitalario Universitario de Vigo, Hospital Xeral, Universidad de Santiago de Compostela, Vigo, Pontevedra, España.
Enferm Infecc Microbiol Clin. 2010 Mar;28(3):150-5. doi: 10.1016/j.eimc.2009.06.003. Epub 2009 Aug 15.
Osteonecrosis (ON) of the hip in human immunodeficiency virus (HIV)-infected patients has been related to corticosteroid use, dyslipidemia, alcoholism, lipodystrophy, antiretroviral drug use, and HIV infection, itself. The aim of this study was to evaluate the prevalence of silent ON of the hip in HIV-infected patients and its association with several risk factors.
From a total of 1200 patients followed up at the HIV clinic of Xeral-Cies Hospital in Vigo (Spain), we selected those diagnosed with HIV infection before January 2006, aged 20-70 years, who came to the clinic during the period of March to May 2008. Patients with a diagnosis of ON of the hip and those with current symptoms were excluded. A magnetic resonance imaging (MRI) study of the hips was performed.
Ninety-seven Caucasian patients (68 men) with a median age of 44 years were included. ON of the hip was detected in 4 patients (4.1%), with bilateral involvement in 2 patients. All 4 patients were men, with a median age of 44.5 years. Several risk factors for ON of the hip were recorded in each patient. CD4 lymphocyte nadir (P=0.034), percentage of patients with CDC stage C (P=0.039), and number of patients with previous corticosteroid treatment (P=0.042) were significantly different between patients with ON of the hip and those with normal MRI findings.
The prevalence of asymptomatic ON of the hip in HIV-infected patients was 4.1%. The most important risk factors for developing this condition were corticosteroid treatment, lower CD4 lymphocyte nadir, and AIDS-defining disease. Antiretroviral treatment was not associated with osteonecrosis.
人类免疫缺陷病毒(HIV)感染患者的髋部骨坏死(ON)与使用皮质类固醇、血脂异常、酗酒、脂肪代谢障碍、抗逆转录病毒药物使用以及HIV感染本身有关。本研究的目的是评估HIV感染患者髋部无症状ON的患病率及其与多种危险因素的关联。
从西班牙维戈市塞拉尔-谢斯医院HIV门诊随访的1200例患者中,我们选取了2006年1月前诊断为HIV感染、年龄在20至70岁之间、于2008年3月至5月期间前来门诊的患者。排除诊断为髋部ON的患者和有当前症状的患者。对髋部进行了磁共振成像(MRI)检查。
纳入了97例白种人患者(68例男性),中位年龄为44岁。4例患者(4.1%)检测出髋部ON,其中2例为双侧受累。所有4例患者均为男性,中位年龄为44.5岁。每位患者均记录了多种髋部ON的危险因素。髋部ON患者与MRI检查结果正常的患者之间,CD4淋巴细胞最低点(P = 0.034)、疾病控制中心C期患者百分比(P = 0.039)以及既往接受皮质类固醇治疗的患者数量(P = 0.042)存在显著差异。
HIV感染患者髋部无症状ON的患病率为4.1%。发生这种情况的最重要危险因素是皮质类固醇治疗、较低的CD4淋巴细胞最低点以及艾滋病界定疾病。抗逆转录病毒治疗与骨坏死无关。